Ajooni Biotech Limited — Updates

Ajooni Biotech has informed the stock exchanges that it has received the confirmation certificate for its quarterly compliance with SEBI regulations. This document confirms that the company has successfully deposited the shares of its shareholders into the designated depository accounts for the quarter ending June 30, 2026.

For investors, this is a standard regulatory requirement that ensures the smooth functioning of the securities market. Meeting this compliance deadline is a positive signal, indicating that the company's share transfer processes are being handled correctly and that there are no delays in the dematerialization of shares. It is a routine administrative update that does not typically impact the company's business operations or financial performance.

Investors should continue to monitor the company's regular financial disclosures for any material updates. While this compliance certificate is a routine procedural step, it reinforces the company's adherence to corporate governance standards.